Author

Sikhulile Moyo

University of Stellenbosch, Division of Medical Virology; Botswana-Harvard AIDS Institute - Cited by 7,016 - Medical Virology - Phylogenetics - HIV epidemiology - Cross-Sectional Incidence - HIV Incidence

Biography

Dr.Sikhulile Moyo received Doctor of Philosophy in medical virology from Stellenbosch University,South Africa during 2012-2015.He completed Master’s Degree in the field of Public Health from University of Limpopo during 2004 – 2006.He received his Master’s Degree in the field of Applied Microbiology from University of Botswana during 1997 – 1999 and currently he is a laboratory manager and scientist at Botswana Harvard AIDS Institute.He had more than 65 publications on topics like phylogenic analysis,molecular phylogenetics,Evolutionary Bioinformatics and viral evolution.He also knows about pathology,Molecular virology,Bio statistics.
Title
Cited by
Year
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ...Nature 603 (7902), 679-686, 2022202
1076
2022
Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa
H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ...Nature medicine 28 (9), 1785-1790, 2022202
328
2022
Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages
H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ...MedRxiv, 2022.05. 01.22274406, 2022202
88
2022
Kosakovsky Pond SL
R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ...Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ …, 2022202
63
2022
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ...Science 378 (6615), eabq5358, 2022202
42
2022
An early warning system for emerging SARS-CoV-2 variants
L Subissi, A von Gottberg, L Thukral, N Worp, BB Oude Munnink, ...Nature medicine (6), 1110-1115, 2022202
28
2022
Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial–BCPP/Ya Tsie trial
LE Magosi, Y Zhang, T Golubchik, V DeGruttola, ET Tchetgen, V Novitsky, ...Elife 11, e72657, 2022202
10
2022
Safety and pharmacokinetics of intravenous 10-1074 and VRC01LS in young children
EV Capparelli, G Ajibola, K Maswabi, MP Holme, K Bennett, KM Powis, ...JAIDS Journal of Acquired Immune Deficiency Syndromes 91 (2), 182-188, 2022202
6
2022
Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana
NO Moraka, P Garcia-Broncano, Z Hu, G Ajibola, OT Bareng, ...AIDS (London, England) 35 (15), 2413, 2021202
6
2021
Immune correlates of HIV-1 reservoir cell decline in early-treated infants
CA Hartana, P Garcia-Broncano, Y Rassadkina, X Lian, C Jiang, ...Cell Reports 40 (3), 2022202
5
2022
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana
OT Bareng, S Moyo, M Zahralban-Steele, D Maruapula, T Ditlhako, ...Journal of Antimicrobial Chemotherapy 77 (5), 1385-1395, 2022202
4
2022
Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana
D Maruapula, KK Seatla, O Morerinyane, K Molebatsi, J Giandhari, ...Medicine 101 (8), e9577, 0
2
2022
Reversal of CSF HIV-1 escape during treatment of HIV-associated cryptococcal meningitis in Botswana
N Kelentse, S Moyo, K Molebatsi, O Morerinyane, S Bitsang, OT Bareng, ...Biomedicines 10 (6), 1399, 0
2
2022
Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
L Tawe, WT Choga, GM Paganotti, OT Bareng, TD Ntereke, P Ramatlho, ...BMC Infectious Diseases (1), 95, 0
2
2022
The role of CYP2B6 516G> T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
The role of CYPB6 516G> T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from BotswanaMJ Maseng, L Tawe, PK Thami, S Moyo, I Kasvosve, V Novitsky, M Essex, ...Medicine 101 (17), 0
2
2022
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana
RL Shapiro, G Ajibola, K Maswabi, M Hughes, BS Nelson, A Niesar, ...Science Translational Medicine 5 (703), eadh0004, 2023202
1
2023
Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana
E Shava, LM Bogart, K Manyake, C Mdluli, K Maribe, N Monnapula, ...Plos one 6 (), e0259508, 20220
1
2021
High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
BB Phinius, M Anderson, I Gobe, M Mokomane, WT Choga, SR Mutenga, ...Open Forum Infectious Diseases 0 (), ofac707, 2023202
1
2023
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana
High concordance in plasma and CSF HIV- drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in BotswanaN Kelentse, S Moyo, WT Choga, K Lechiile, TB Leeme, DS Lawrence, ...Journal of Antimicrobial Chemotherapy 78 (), 80-84, 2023202
1
2023
Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency …
M Jackson-Gibson, M Diseko, EC Caniglia, GK Mayondi, J Mabuta, ...Obstetrics & Gynecology 4 (), 35-43, 2023202
1
2023

Referred From: https://scholar.google.com/citations?hl=en&user=Q5GCt9sAAAAJ

Cited by
Citations 7016
h-index 39
i10-index 110
Recommended Journals
Open Access Journals